BTC
ELV icon

Bank & Trust Company’s Elevance Health ELV Stock Holding History

Bank & Trust Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Hold
50
– – 0.01% 212
2026
Q1 		$14.6K Hold
50
– – 0.01% 224
2025
Q4 		$17.5K Hold
50
– – 0.01% 207
2025
Q3 		$16.2K Hold
50
– – 0.01% 202
2025
Q2 		$19.4K Hold
50
– – 0.02% 191
2025
Q1 		$21.7K Hold
50
– – 0.02% 183
2024
Q4 		$18.4K Hold
50
– – 0.02% 188
2024
Q3 		$26K Hold
50
– – 0.02% 170
2024
Q2 		$27.1K Buy
+50
New +$26.4K 0.02% 169

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bank & Trust Company's ELV Position: Q2 2026 in Review

Bank & Trust Company held its Elevance Health (ELV) position steady in Q2 2026 at 50 shares worth $19.3K. The position accounts for 0.01% of the portfolio, ranked #212.

Bank & Trust Company first reported a position in ELV in Q2 2024 and has held it in 9 quarters since. The position peaked at $27.1K in Q2 2024. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bank & Trust Company held 50 shares of Elevance Health worth $19.3K as of Q2 2026.
  • Bank & Trust Company left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.01% of Bank & Trust Company's portfolio in Q2 2026, its #212 holding.
  • Bank & Trust Company first reported a position in Elevance Health in Q2 2024 and has held it in 9 quarters since.
  • Bank & Trust Company's Elevance Health position peaked at $27.1K in Q2 2024.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.